http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-30703-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-00
filingDate 2007-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58795acf77a7ad460a83d513d7a32af9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eff790a7826c504c14922610211abae3
publicationDate 2008-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UY-30703-A1
titleOfInvention USE OF AGOMELATINE FOR THE OBTAINING OF DRUGS INTENDED FOR THE TREATMENT OF PERIVENTRICULAR LEUCOMALACY
abstract The present invention relates to the use of agomelatine or N- [2-7-methoxy-1-naphthyl) ethyl] acetamide for obtaining medicaments for the treatment of periventricular leukomalacia.
priorityDate 2006-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82148

Total number of triples: 22.